• Home
  • News
  • Fortune 500
  • Tech
  • Finance
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Bayer Has Reportedly Signed $66 Billion Deal to Buy Monsanto

By
Reuters
Reuters
By
Reuters
Reuters
September 14, 2016, 6:10 AM ET
GERMANY-CHEMICALS-PHARMACEUTICAL-EARNINGS-MANAGEMENT-BAYER
Photograph by Oliver Berg AFP/Getty Images

This story is developing and will be updated as events unfold.

Bayer won over Monsanto’s management with a $128 per-share cash offer to acquire the global seed market leader, a person familiar with the matter said, in a move to command more than a quarter of the combined world market for seeds and pesticides.

Bayer has signed a deal that includes a fee of $2 billion should the transaction fail to get regulatory clearance as planned, the person said. The deal is expected to close by the end of 2017, the source told Reuters on Wednesday.

Monsanto (MON) and Bayer @bayer(BAYRY)were not immediately available for comment.

Shares in Bayer extended gains to trade 3% higher on the news.

At a total deal value of close to $66 billion—based on 442 million Monsanto shares and the U.S. group’s net debt of $9.3 billion as per end-May—it will be the largest transaction ever involving a German buyer.

It would trump Daimler’s merger deal with Chrysler in 1998, which valued the U.S. carmaker at more than $40 billion. It will also be the largest all-cash transaction on record, ahead of brewer InBev’s $60.4 billion offer for Anheuser-Busch in 2008.

The two companies were in talks to sound out ways to combine their businesses as early as March, which culminated in Bayer coming out with an initial $122 per-share takeover proposal in May.

About the Author
By Reuters
See full bioRight Arrow Button Icon
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Leadership
  • Success
  • Tech
  • Asia
  • Europe
  • Environment
  • Fortune Crypto
  • Health
  • Retail
  • Lifestyle
  • Politics
  • Newsletters
  • Magazine
  • Features
  • Commentary
  • Mpw
  • CEO Initiative
  • Conferences
  • Personal Finance
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map

© 2025 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.